Logo image of HAPB.CA

HAPBEE TECHNOLOGIES-SUB VTG (HAPB.CA) Stock Fundamental Analysis

Canada - TSX-V:HAPB - CA41136M1023 - Common Stock

0.055 CAD
0 (0%)
Last: 11/5/2025, 7:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to HAPB. HAPB was compared to 0 industry peers in the Unkown industry. HAPB has a bad profitability rating. Also its financial health evaluation is rather negative. HAPB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HAPB had negative earnings in the past year.
HAPB had a negative operating cash flow in the past year.
In the past 5 years HAPB always reported negative net income.
In the past 5 years HAPB always reported negative operating cash flow.
HAPB.CA Yearly Net Income VS EBIT VS OCF VS FCFHAPB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

Industry RankSector Rank
ROA -171.04%
ROE N/A
ROIC N/A
ROA(3y)-181.65%
ROA(5y)-163.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HAPB.CA Yearly ROA, ROE, ROICHAPB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 1K 2K

1.3 Margins

HAPB's Gross Margin has improved in the last couple of years.
HAPB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.68%
GM growth 5YN/A
HAPB.CA Yearly Profit, Operating, Gross MarginsHAPB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

0

2. Health

2.1 Basic Checks

HAPB does not have a ROIC to compare to the WACC, probably because it is not profitable.
HAPB has more shares outstanding than it did 1 year ago.
HAPB has a worse debt/assets ratio than last year.
HAPB.CA Yearly Shares OutstandingHAPB.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
HAPB.CA Yearly Total Debt VS Total AssetsHAPB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

HAPB has an Altman-Z score of -18.49. This is a bad value and indicates that HAPB is not financially healthy and even has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -18.49
ROIC/WACCN/A
WACC8.38%
HAPB.CA Yearly LT Debt VS Equity VS FCFHAPB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M

2.3 Liquidity

HAPB has a Current Ratio of 0.30. This is a bad value and indicates that HAPB is not financially healthy enough and could expect problems in meeting its short term obligations.
HAPB has a Quick Ratio of 0.30. This is a bad value and indicates that HAPB is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.3
Quick Ratio 0.23
HAPB.CA Yearly Current Assets VS Current LiabilitesHAPB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

1

3. Growth

3.1 Past

HAPB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.08%, which is quite impressive.
HAPB shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.54%.
HAPB shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -37.37% yearly.
EPS 1Y (TTM)30.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.77%
Revenue 1Y (TTM)33.54%
Revenue growth 3Y-37.37%
Revenue growth 5YN/A
Sales Q2Q%299.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HAPB.CA Yearly Revenue VS EstimatesHAPB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HAPB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HAPB.CA Price Earnings VS Forward Price EarningsHAPB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HAPB.CA Per share dataHAPB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.01 -0.02 -0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HAPB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HAPBEE TECHNOLOGIES-SUB VTG

TSX-V:HAPB (11/5/2025, 7:00:00 PM)

0.055

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)07-18 2025-07-18
Earnings (Next)11-04 2025-11-04
Inst Owners0.05%
Inst Owner ChangeN/A
Ins Owners32.94%
Ins Owner ChangeN/A
Market Cap12.41M
Revenue(TTM)1.02M
Net Income(TTM)-4362300
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.65
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.01
BVpS-0.02
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -171.04%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.24%
FCFM N/A
ROA(3y)-181.65%
ROA(5y)-163.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.68%
GM growth 5YN/A
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.3
Quick Ratio 0.23
Altman-Z -18.49
F-Score3
WACC8.38%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)33.54%
Revenue growth 3Y-37.37%
Revenue growth 5YN/A
Sales Q2Q%299.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-46.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.9%
OCF growth 3YN/A
OCF growth 5YN/A

HAPBEE TECHNOLOGIES-SUB VTG / HAPB.CA FAQ

What is the ChartMill fundamental rating of HAPBEE TECHNOLOGIES-SUB VTG (HAPB.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to HAPB.CA.


What is the valuation status for HAPB stock?

ChartMill assigns a valuation rating of 0 / 10 to HAPBEE TECHNOLOGIES-SUB VTG (HAPB.CA). This can be considered as Overvalued.


Can you provide the profitability details for HAPBEE TECHNOLOGIES-SUB VTG?

HAPBEE TECHNOLOGIES-SUB VTG (HAPB.CA) has a profitability rating of 1 / 10.